ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule.
Liu D, Shu G, Jin F, Qi J, Xu X, Du Y, Yu H, Wang J, Sun M, You Y, Zhu M, Chen M, Zhu L, Shen Q, Ying X, Lou X, Jiang S, Du Y.
Liu D, et al. Among authors: yu h.
Sci Adv. 2020 Oct 9;6(41):eabb7422. doi: 10.1126/sciadv.abb7422. Print 2020 Oct.
Sci Adv. 2020.
PMID: 33036968
Free PMC article.